Haemonetics Corporation Legal Fees
Haemonetics Corporation (HAE) reported Legal Fees of $15.66 million for the 12-month period ending 2021-04-03, per its 10-K filed 2021-05-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2021-05-26
- Haemonetics Corporation legal fees for the quarter ending 2019-03-30 was $11.37M.
- Haemonetics Corporation legal fees for the quarter ending 2018-12-29 was $4.82M, a 60.15% increase year-over-year.
- Haemonetics Corporation legal fees for the quarter ending 2018-09-29 was $4.44M.
- Haemonetics Corporation legal fees for the quarter ending 2018-06-30 was $675.00K.
- Haemonetics Corporation legal fees for fiscal 2021 was $15.66M, a 21.21% decline from fiscal 2020.
- Haemonetics Corporation legal fees for fiscal 2020 was $19.88M, a 45.52% increase from fiscal 2019.
- Haemonetics Corporation legal fees for fiscal 2019 was $13.66M.
- Haemonetics Corporation legal fees for fiscal 2018 was $0.00.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month | Legal Fees 12 month as first filed |
|---|---|---|---|---|---|
| 2021-04-03 | $15.66M 10-K · filed 2021-05-26 | ||||
| 2020-03-28 | $19.88M 10-K · filed 2021-05-26 | $8.08M 10-K · filed 2020-05-20 | |||
| 2019-03-30 | $11.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-26 | $16.19M derived: sum of 2 quarters · filed 2021-05-26 | $20.64M derived: sum of 3 quarters · filed 2021-05-26 | $13.66M 10-K · filed 2021-05-26 | $2.73M 10-K · filed 2019-05-22 |
| 2018-12-29 | $4.82M 10-Q · filed 2019-02-05 | $9.26M derived: sum of 2 quarters · filed 2019-02-05 | $2.29M 10-Q · filed 2019-02-05 | $6.93M derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-09-29 | $4.44M 10-Q · filed 2018-11-06 | $675.00K 10-Q · filed 2018-11-06 | $2.11M derived: sum of 3 quarters · filed 2020-05-20 | $5.12M derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-06-30 | $675.00K 10-Q · filed 2018-08-07 | -$2.34M derived: sum of 2 quarters · filed 2020-05-20 | $675.00K derived: sum of 3 quarters · filed 2020-05-20 | $675.00K derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-03-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-20 | $0.00 derived: sum of 2 quarters · filed 2020-05-20 | $0.00 derived: sum of 3 quarters · filed 2020-05-20 | $0.00 10-K · filed 2020-05-20 | $3.01M 10-K · filed 2018-05-23 |
| 2017-12-30 | $3.01M 10-Q · filed 2019-02-05 | $3.01M derived: sum of 2 quarters · filed 2019-02-05 | $3.01M 10-Q · filed 2018-02-06 | $3.01M derived: sum of 4 quarters · filed 2019-05-22 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | $0.00 derived: sum of 3 quarters · filed 2019-05-22 | $0.00 derived: sum of 4 quarters · filed 2019-05-22 | |
| 2017-07-01 | $0.00 10-Q · filed 2018-08-07 | $0.00 derived: sum of 2 quarters · filed 2019-05-22 | $0.00 derived: sum of 3 quarters · filed 2019-05-22 | ||
| 2017-04-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-22 | $0.00 derived: sum of 2 quarters · filed 2019-05-22 | $0.00 10-K · filed 2019-05-22 | ||
| 2016-12-31 | $0.00 10-Q · filed 2018-02-06 | $0.00 10-Q · filed 2018-02-06 | |||
| 2016-04-02 | $0.00 10-K · filed 2018-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |